| Literature DB >> 30650349 |
Long Zhao1, Raz Ben-Yair1, Caroline E Burns2, C Geoffrey Burns3.
Abstract
Previous studies demonstrate that the regenerative zebrafish heart responds to injury by upregulating Notch receptors in the endocardium and epicardium. Moreover, global suppression of Notch activity following injury impairs cardiomyocyte proliferation and induces scarring. However, the lineage-specific requirements for Notch signaling and full array of downstream targets remain unidentified. Here, we demonstrate that inhibition of endocardial Notch signaling following ventricular amputation compromises cardiomyocyte proliferation and stimulates fibrosis. RNA sequencing uncovered reduced levels of two transcripts encoding secreted Wnt antagonists, Wif1 and Notum1b, in Notch-suppressed hearts. Like Notch receptors, wif1 and notum1b are induced following injury in the endocardium and epicardium. Small-molecule-mediated activation of Wnt signaling is sufficient to impair cardiomyocyte proliferation and induce scarring. Last, Wnt pathway suppression partially restored cardiomyocyte proliferation in hearts experiencing endocardial Notch inhibition. Taken together, our data demonstrate that Notch signaling supports cardiomyocyte proliferation by dampening myocardial Wnt activity during zebrafish heart regeneration.Entities:
Keywords: Notch; Wnt; cardiac repair; cardiomyocyte proliferation; heart regeneration; notum; wif; zebrafish
Mesh:
Substances:
Year: 2019 PMID: 30650349 PMCID: PMC6366857 DOI: 10.1016/j.celrep.2018.12.048
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423
Figure 1.Endocardial Notch Signaling Is Required for Cardiomyocyte Proliferation during Zebrafish Heart Regeneration
(A) Schematic diagram of the transgene, and its Cre-dependent recombination, used to achieve tissue-specific, heat shock-inducible inhibition of Notch signaling. (B and C) Single confocal slices of cardiac sections from Tg(kdrl:CreER), Tg(hsp70l: mKate2STOPDN-MAML) animals treated during embryogenesis with EtOH (CRTL) (B) or 4-HT (Tg(hsp70l:DN-MAML); abbreviated Tg(DNMAML)) (C), raised to adulthood, heat shocked once, and sacrificed 5 hr later for analysis. Sections were double immunostained for MF20 (magenta) and GFP (green) and counterstained with DAPI (blue). Greater than three sections from more than 5 hearts per group were examined. Little to no variation was observed. (D) Double-transgenic strain and experimental strategy employed to inhibit Notch signaling specifically in endocardial cells during zebrafish heart regeneration. (E–J) Cardiac sections from kdrl:CreER, hsp70l:mKate2STOPDN-MAML animals treated during embryogenesis with EtOH (CRTL) (E, G, and I) or 4-HT (Tg(hsp70l:DN-MAML); abbreviated Tg(DN-MAML)) (F, H, and J), raised to adulthood, subjected to ventricular apex amputation, and heat shocked daily. (E and F) Single confocal slices of cardiac sections from 30 days post-amputation (dpa) animals immunostained for MF20 (magenta) and counterstained with DAPI (blue). Dashed lines approximate the amputation planes. The asterisk in (F) highlights a gap in the myocardial wall. (G and H) Cardiac sections from 30 dpa animals stained with AFOG to detect muscle (brown), fibrin (red), and collagen (blue). The asterisk in (H) highlights collagen-rich scar tissue (H). Myocardial regeneration occurred in 10/10 CTRL and 1/16 Tg(DN-MAML) hearts. (I and J) Compound microscopic images of cardiac sections from 7 dpa CTRL and Tg(DN-MAML) animals double immunostained to detect cardiomyocyte nuclei (a-Mef2 antibody; red) and cycling cells (α-PCNA antibody; green). (K) Bar graph showing cardiomyocyte proliferation indices on 7 dpa in CTRL (n = 6) and Tg(DM-MAML) (n = 5) hearts. Proliferation data were collected for 4–6 sections per heart and averaged to generate each data point. Statistical significance was determined using a Student’s t test. Error bars: ±1 SD. **p < 0.01. Scale bars: 50 μm.
Figure 2.Identification of Secreted Wnt Signaling Antagonists as Candidate Notch Targets in the Endocardium during Zebra-fish Heart Regeneration
(A) Heatmap showing 254 differentially expressed genes (p < 0.0001) in wild-type (CTRL; n = 3 replicates) and Tg(hsp70l:DN-MAML) (n = 3 replicates) hearts on 5 dpa with daily heat shocking. (B) Bar graph showing −log10 p values for GO terms significantly overrepresented in the down-regulated gene category. (C) Bar graph showing the log2 fold-change values for transcripts encoding wif1 and notum1b from (A). (D) Bar graph showing the relative expression levels of wif1 and notum1b in hearts of CTRL and hsp70l:DN-MAML animals on 5 dpa with daily heat shocking as measured by qPCR. (E) Bar graph showing the relative expression levels of wif1 and notum1b in hearts of wild-type animals without injury and on 7 dpa as measured by qPCR. (D and E) 3 technical replicates of each of 3 biological replicates were performed. Statistical significance was determined using a Student’s t test. Error bars: ±1 SD. ****p < 0.0001. *p < 0.05. (F–G′) In situ hybridization for wif1 and notum1b in cardiac sections of wild-type hearts on 7 dpa. Boxed regions in (F) and (G) are enlarged in (F′) and (G′). Arrowheads highlight endocardial signals. 6–8 sections from 4–6 hearts were analyzed. Little to no variation was observed. (H–I′) Immunohistochemical analysis of Wif1 (H and H′; yellow) and Notum (I and I′; cyan) in cardiac sections of wild-type hearts on 7 dpa costained with the MF20 antibody (magenta) to visualize myocardium. Single confocal slices are shown. Dashed lines highlight approximate amputation planes. 6–8 sections from 4–6 hearts were analyzed. Little to no variation was observed. Scale bars: 50 μm.
Figure 3.Notch Inhibition Boosts Wnt Signaling in the Myocardium of Injured Zebrafish Hearts
(A and B) Confocal slices of cardiac sections from 5 dpa Tg(7xTCF:eGFP) animals injected daily with DMSO (A) or N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) (B). Animals were double immunostained to detect GFP (green) and myocardium (MF20 antibody; magenta) and counterstained with DAPI (blue). (C–D″) Boxed regions in (A) and (B) are shown at higher magnification in (C) and (D). Split channels are shown in (C′), (C″), (D′), and (D″). Arrows point to myocardial cells with active Wnt signaling. n = 3 hearts per experimental group. At least 3 sections were examined per heart. Little to no variability was observed between animals in each experimental group.
Figure 4.Inhibition of Wnt Signaling Is Required for Zebrafish Heart Regeneration by Bolstering Myocardial Proliferation
(A) Experimental strategy used to inhibit or augment Wnt signaling during the regenerative window. Injured animals were injected intraperitoneally (IP) with DMSO, IWR, or BIO on 5 and 6 dpa before cardiomyocyte proliferation was measured on 7 dpa. Myocardial regeneration was examined on 30 dpa followed by IP injection of DMSO, IWR, or BIO every other day throughout 2–30 dpa. (B–G) Cardiac sections from 30 dpa wild-type animals injected with DMSO (B and E), IWR (C and F), or BIO (D and G). Single confocal slices of sections immunostained with MF20 (magenta) and counterstained with DAPI (blue) are shown in (B)–(D). Sections stained with AFOG to visualize muscle (brown), fibrin (red), and collagen (blue) are shown in (E)–(G). Asterisks in (D) and (G) highlight gaps in the myocardial wall filled with collagen-rich scar tissue. Heart regeneration occurred in 7/8 DMSO-treated, 4/7 IWR-treated, and 2/8 BIO-treated animals. (H–J′) Cardiac sections from 7 day post-amputation wild-type animals treated with DMSO (H and H′), IWR (I and I′), and BIO (J and J′) were double immunostained to detect cardiomyocyte nuclei (Mef2 antibody; red) and cycling cells (α-PCNA antibody; green). Compound microscopic images are shown. (K) Bar graph showing cardiomyocyte proliferation indices for the indicated experimental groups (DMSO, n = 4; IWR, n = 4; BIO, n = 5). 4–6 sections per heart were analyzed and averaged to generate each data point. Statistical significance was determined using a Student’s t test. Error bars: ±1 SD. *p < 0.05. ***p < 0.001. Scale bars: 50 μm.
Figure 5.Wnt Inhibition Partially Rescues Cardiomyocyte Proliferation Deficits Caused by Impaired Endocardial Notch Signaling
(A) Double-transgenic strain and schematic diagram of experimental timeline used to inhibit Wnt signaling in animals with compromised endocardial Notch signaling. (B–E′) Compound microscopic images of cardiac sections from kdrl:CreER, hsp70l: mKate2STOPDN-MAML animals treated during embryogenesis with EtOH (CTRL) (B–C′) or 4-HT (hsp70l:DN-MAML) (D–E′), raised to adulthood, and subjected to ventricular apex amputation. Thereafter, animals were heat shocked daily and treated with DMSO (B, B′, D, and D′) or the Wnt inhibitor IWR-1 (C, C′, E, and E′) before cardiomyocyte proliferation analysis on 7 dpa. Sections were double immunostained to detect cardiomyocyte nuclei (Mef2 antibody; red) and cycling cells (PCNA antibody; green). Boxed regions in (B), (C), (D), and (E) are enlarged in (B′), (C′), (D′), and (E′). (F) Bar graph showing the cardiomyocyte proliferation indices for the indicated experimental groups (CTRL, n = 6; Wnt Inhib, n = 10; NotchEC Inhib, n = 6; NotchEC and Wnt Inhib, n = 10). 4–6 sections per heart were analyzed and averaged to generate each data point. Statistical significance was determined using a Student’s t test. Error bars: ±1 SD. ***p < 0.001. ****p < 0.0001. **p < 0.01. Scale bars: 50 μm. (G) Schematic diagram showing the influence of endocardial Notch on Wnt signaling and cardiomyocyte proliferation.
KEY RESOURCES TABLE
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Antibodies | ||
| Mouse monoclonal MF20 | Deposited to the Developmental Studies Hybridoma Bank by Fischman, D.A. | DSHB Cat# MF20; RRID: AB_2147781 |
| Mouse monoclonal anti-mCherry | Abcam | Cat# ab125096; RRID: AB_11133266 |
| Rabbit polyclonal anti-GFP | Abcam | Cat# ab290; RRID: AB_303395 |
| Chicken polyclonal anti-GFP | Abcam | Cat# ab13970; RRID: AB_300798 |
| Rabbit polyclonal anti-Wif1 | GeneTex | Cat# GTX16429; |
| Rabbit polyclonal anti-Notum | GeneTex | Cat# GTX85260; RRID: AB_10722930 |
| Rabbit polyclonal anti-Mef2 | Santa Cruz Biotechnology | Cat# sc-313; RRID: AB_631920 |
| Mouse monoclonal anti-PCNA | Sigma-Aldrich | Cat# WH0005111M2; RRID: AB_1842895 |
| Mouse monoclonal anti-pan Cytokeratin | Abcam | Cat# ab86734; RRID: AB_10674321 |
| Mouse monoclonal anti- Collagen, Type I pro-peptide | Deposited to the Developmental Studies Hybridoma Bank by Furthmayr, H. | DSHB Cat# SP1 .D8; RRID: AB_528438 |
| Goat anti-Mouse IgG (H+L) Cross-Absorbed Secondary Antibody, Alexa Fluor 488 | Thermo Fisher Scientific | Cat# A-11029; RRID: AB_2534088 |
| Goat anti-Rabbit IgG (H+L) Cross-Absorbed Secondary Antibody, Alexa Fluor 488 | Thermo Fisher Scientific | Cat# A-11008; RRID: AB_143165 |
| Goat anti-Mouse IgG2b Cross-Absorbed Secondary Antibody, Alexa Fluor 546 | Thermo Fisher Scientific | Cat# A-21143; RRID: AB_2535779 |
| Goat anti-Mouse IgG (H+L) Cross-Absorbed Secondary Antibody, Alexa Fluor 555 | Thermo Fisher Scientific | Cat# A-21424; RRID: AB_141780 |
| Goat anti-Mouse IgG1 Cross-Absorbed Secondary Antibody, Alexa Fluor 568 | Thermo Fisher Scientific | Cat# A-21124; RRID: AB_2535766 |
| Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 568 | Thermo Fisher Scientific | Cat# A-11036; RRID: AB_10563566 |
| Goat anti-Chick IgY (H+L) Cross-Absorbed Secondary Antibody, Alexa Fluor 633 | Thermo Fisher Scientific | Cat# A-21103; RRID: AB_2535756 |
| Goat anti-Mouse IgG2b Cross-Absorbed Secondary Antibody, Alexa Fluor 647 | Thermo Fisher Scientific | Cat# A-21242; RRID: AB_2535811 |
| Chemicals, Peptides, and Recombinant Proteins | ||
| Ethyl-Aminobenzoate methanesulfonate salt (MS-222, Tricaine) | Sigma-Aldrich | Cat# A5040 |
| Nitro-Blue Tetrazolium Chloride (NBT) | Promega | Cat# S380C |
| 5-Bromo-4-Chloro-3-Indolyphosposphate | Promega | Cat# S381C |
| 4-Hydroxytamoxifen | Sigma-Aldrich | Cat# H7904 |
| Aniline Blue | Sigma-Aldrich | Cat# 415049 |
| Orange G | Sigma-Aldrich | Cat# O3756 |
| Acid Fuchsin | Sigma-Aldrich | Cat# F8129 |
| Trizol | Invitrogen | Cat# 15596–026 |
| (2’Z,3’E)-6-Bromoindirubin-3’-oxime (BIO) | Sigma-Aldrich | Cat# B1686 |
| IWR-1-endo (IWR) | Sigma-Aldrich | Cat# 681669 |
| Critical Commercial Assays | ||
| DIG RNA Labeling Kit (SP6/T7) | Roche | Cat# 11175025910 |
| TSA-plus DNP system | PerkinElmer | Cat# NEL746A |
| RNeasy Plus Micro Kit | QIAGEN | Cat# 74034 |
| SuperScript III First-Strand Synthesis System | Thermo Fisher Scientific | Cat# 18080051 |
| Fast SYBER Green PCR Master Mix | Thermo Fisher Scientific | Cat# 4385612 |
| Zero Blunt TOPO PCR Cloning Kit | Invitrogen | Cat# 450245 |
| Deposited Data | ||
| RNA Sequencing Data | This paper | GSE107228 |
| Experimental Models: Organisms/Strains | ||
| Zebrafish: | ZFIN: ZDB-ALT-140618–1 | |
| Zebrafish: | ZFIN: ZDB-ALT-140522–6 | |
| Zebrafish: | ZFIN: ZDB-ALT-081212–4 | |
| Zebrafish: | This paper | N/A |
| Zebrafish: | ZFIN: ZDB-ALT-110113–1 | |
| Oligonucleotides | ||
| See | N/A | |
| Recombinant DNA | ||
| N/A | ||
| N/A | ||
| N/A | ||
| pDestTol2pA2 | N/A | |
| This paper | N/A | |
| This paper | N/A | |
| This paper | N/A | |
| Software and Algorithms | ||
| NIS-Elements | Nikon Instruments | RRID: SCR_014329 |
| Fiji/ImageJ | NIH | RRID: SCR_002285 |
| GraphPad Prism 6 | GraphPad Software | RRID: SCR_002798 |
| RStudio | RStudio | |
| Microsoft Excel | Microsoft | RRID: SCR_016137 |
| ClustVis | ||
| PANTHER | ||
| Other | ||
| 4’,6-diamidino-2-phenylindole dihydrochloride (DAPI) | Invitrogen | Cat# D1306; RRID: AB_2629482 |
| VECTASHIELD Antifade Mounting Medium | Vector Laboratories | Cat# H-1000; RRID: AB_2336789 |